Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 2
2005 10
2006 5
2007 3
2008 16
2009 17
2010 15
2011 15
2012 33
2013 35
2014 47
2015 60
2016 68
2017 78
2018 74
2019 96
2020 131
2021 114
2022 138
2023 45
Text availability
Article attribute
Article type
Publication date

Search Results

896 results
Results by year
Filters applied: . Clear all
Page 1
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer.
Zhang Y, Chen H, Mo H, Hu X, Gao R, Zhao Y, Liu B, Niu L, Sun X, Yu X, Wang Y, Chang Q, Gong T, Guan X, Hu T, Qian T, Xu B, Ma F, Zhang Z, Liu Z. Zhang Y, et al. Among authors: ma f. Cancer Cell. 2021 Dec 13;39(12):1578-1593.e8. doi: 10.1016/j.ccell.2021.09.010. Epub 2021 Oct 14. Cancer Cell. 2021. PMID: 34653365 Free article.
Antibody-drug conjugates in HER2-positive breast cancer.
Li L, Zhang D, Liu B, Lv D, Zhai J, Guan X, Yi Z, Ma F. Li L, et al. Among authors: ma f. Chin Med J (Engl). 2021 Dec 22;135(3):261-267. doi: 10.1097/CM9.0000000000001932. Chin Med J (Engl). 2021. PMID: 34935688 Free PMC article. Review.
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial.
Xu B, Yan M, Ma F, Hu X, Feng J, Ouyang Q, Tong Z, Li H, Zhang Q, Sun T, Wang X, Yin Y, Cheng Y, Li W, Gu Y, Chen Q, Liu J, Cheng J, Geng C, Qin S, Wang S, Lu J, Shen K, Liu Q, Wang X, Wang H, Luo T, Yang J, Wu Y, Yu Z, Zhu X, Chen C, Zou J; PHOEBE Investigators. Xu B, et al. Among authors: ma f. Lancet Oncol. 2021 Mar;22(3):351-360. doi: 10.1016/S1470-2045(20)30702-6. Epub 2021 Feb 11. Lancet Oncol. 2021. PMID: 33581774 Clinical Trial.
896 results